Background Intrahepatic distant recurrence (IDR) is a significant problem for patients who
have undergone radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The …

Objective This study aims to determine the risk factors, patterns, and long-term survival
outcomes of late recurrence after radiofrequency ablation (RFA) for hepatocellular …

Objective Early tumor recurrence, either local or intrahepatic distant recurrence (IDR), after
successful radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) remains a …

Objective To determine the efficacy of radiofrequency ablation (RFA) for initial recurrence of
small hepatocellular carcinoma (HCC;≤ 3 nodules, each nodule≤ 3 cm in diameter) after …

Objective To define an optimal cutoff time to distinguish early and late recurrence in
hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to …

Background Surgical resection (SR) and radiofrequency ablation (RFA) are reasonable
treatment options for early recurrent hepatocellular carcinoma (rHCC), but it is still uncertain …

Purpose To determine the risk factors and patterns of recurrence after radiofrequency
ablation (RFA) for hepatocellular carcinoma (HCC) meeting the up-to-seven criteria and to …

Aim Although radiofrequency ablation (RFA) is an effective local treatment of hepatocellular
carcinoma (HCC), local recurrence is relatively frequent. We aimed to elucidate the validity …

Background & Aims Radiofrequency ablation (RFA) is an effective treatment for single
hepatocellular carcinoma (HCC)≤ 3 cm. Disease recurrence is common, and in some …

Aim: To compare the overall survival (OS) in patients without recurrent hepatocellular
carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with recurrence …